Type of security: Stock
Sector: Capital Goods
The data is delayed by 15 minutes.
IART is in the long-term up 319% in 12 years.
Description: Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in five segments: U.S. Neurosurgery, U.S. Extremities, U.S. Instruments, U.S. Spine and Other, and International. Its orthopedics products include specialty metal implants for surgery of the extremities, shoulder, and spine; orthobiologic products for repair and grafting of bone, including demineralized bone products, collagen ceramic matrices, and synthetic bone grafting solutions; dermal regeneration products and tissue-engineered wound dressings; and nerve and tendon repair products. The company also offers spinal fusion technologies comprising integrated interbody fusion devices, minimally invasive solutions, and deformity correction products; and neurosurgery and critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devi
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||EPS||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||1%||Sales Growth - Q/Q||-7.34%||P/E|
|P/E To EPS Growth||P/S||P/BV||Price/Cash Per Share|
|Price/Free Cash Flow||ROA||2.59%||ROE||5.84%||ROI||3.02%|
|Current Ratio||4.12||Quick Ratio||2.28||Long Term Debt/Equity||1.55||Debt Ratio||0.18|
|Gross Margin||62.28%||Operating Margin||7.77%||Net Profit Margin||4.24%||Dividend Payout Ratio|
|Cash From Financing Activities||30.45 M||Cash From Investing Activities||-18.74 M||Cash From Operating Activities||49.74 M||Gross Profit||157.54 M|
|Net Profit||5 M||Operating Profit||13.95 M||Total Assets||1.64 B||Total Current Assets||608.25 M|
|Total Current Liabilities||155.75 M||Total Debt||654.14 M||Total Liabilities||926.17 M||Total Revenue||244.08 M|
|High 52 week||65.87||Low 52 week||42.62||Last close||61.85||Last change||2.11%|
|RSI||53.53||Average true range||1.4||Beta||0.67||Volume||390.34 K|
|Simple moving average 20 days||2.95%||Simple moving average 50 days||2.07%||Simple moving average 200 days||13.93%|
|Performance Week||6.77%||Performance Month||1.76%||Performance Quart||14.66%||Performance Half||17.45%|
|Performance Year||-3.1%||Performance Year-to-date||37.14%||Volatility daily||1.4%||Volatility weekly||3.13%|
|Volatility monthly||6.42%||Volatility yearly||22.25%||Relative Volume||322.8%||Average Volume||416.06 K|
|New High||New Low|
2020-03-30 12:09:04 | Syneos Health Launches Initiative for COVID-19 Patients
2020-03-26 16:49:33 | These Hedge Funds Sold Out Of Integra Lifesciences Holdings IART At The Right Time
2020-03-26 11:40:03 | IART vs. ABMD: Which Stock Is the Better Value Option?
2020-03-26 09:42:01 | Stellar Codman Surgical Sales Aid Integra Amid Supply Issues
2020-03-20 11:30:03 | Why Is Integra IART Down 37.3% Since Last Earnings Report?
2020-03-17 17:23:09 | Here's Why You Should Buy Integra LifeSciences Stock Now
2020-03-10 11:40:03 | IART vs. ABMD: Which Stock Should Value Investors Buy Now?
2020-02-28 08:05:01 | Integra Launches AmnioExcel Placental Allograft Membrane
2020-02-24 16:15:10 | Integra LifeSciences Launches AmnioExcel® Plus Placental Allograft Membrane
2020-02-24 09:04:02 | Integra LifeSciences Grows Organically Amid Supply Issues
2020-02-22 11:34:54 | Edited Transcript of IART earnings conference call or presentation 19-Feb-20 1:30pm GMT
2020-02-21 09:54:02 | Integra IART Q4 Earnings Surpass Estimates, Margins Up
2020-02-19 07:30:12 | Integra LifeSciences IART Beats Q4 Earnings Estimates
2020-02-19 07:21:54 | The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
2020-02-12 12:31:05 | Integra LifeSciences IART Reports Next Week: Wall Street Expects Earnings Growth
2020-02-04 19:58:42 | Integra Announces Pricing of Convertible Senior Notes
2020-01-16 07:01:12 | Integra Announces Preliminary Q4 Results, Share Buyback Plan
2019-12-20 13:07:00 | Here’s a lucky batch of 13 stocks that Jefferies thinks are ‘value BUT growing’ for 2020
2019-12-18 09:43:02 | Here's Why You Should Retain Integra LifeSciences Stock Now
2019-12-16 16:01:10 | Integra LifeSciences to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-10-28 09:30:01 | IART vs. TCMD: Which Stock Is the Better Value Option?
2019-10-25 10:27:02 | Integra LifeSciences' IART Earnings Top Estimates in Q3
2019-10-25 02:11:23 | Edited Transcript of IART earnings conference call or presentation 24-Oct-19 12:30pm GMT
2019-10-24 07:30:11 | Integra LifeSciences IART Tops Q3 Earnings and Revenue Estimates
2019-10-24 06:00:05 | Integra LifeSciences Reports Third Quarter 2019 Financial Results
2019-10-17 15:00:42 | Hedge Funds Have Never Been This Bullish On Integra Lifesciences Holdings Corp IART
2019-10-17 10:34:02 | Integra LifeSciences IART Reports Next Week: Wall Street Expects Earnings Growth
2019-09-11 11:27:03 | Integra Buys Rebound Therapeutics to Boost Neurosurgery Line
2019-09-10 19:15:04 | Integra Lifesciences Holdings Corp IART President & CEO Peter J Arduini Sold $15. ...
2019-09-09 07:30:00 | Integra LifeSciences Acquires Rebound Therapeutics Corporation